The Renal Insufficiency Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the renal insufficiency has seen a quick expansion in recent years. The value will rise from $10.87 billion in 2024 to $12.14 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.7%.
By 2029, the renal insufficiency market is projected to reach a market size of $18.68 billion, with a compound annual growth rate (CAGR) of 11.4%.
Download Your Free Sample of the 2025 Renal Insufficiency Market Report and Uncover Key Trends Now!The key drivers in the renal insufficiency market are:
• The rise in cases of acute kidney injuries (AKI).
• Enhanced adoption of home-based treatment options.
• Increase in healthcare expenditure.
• Larger investments in research and development.
The renal insufficiency market covered in this report is segmented –
1) By Treatment Type: Medications, Dialysis, Kidney Transplantation, Other Treatment Types
2) By Disease Stage: Chronic Kidney Disease (CKD) Stages, End-Stage Renal Disease (ESRD)
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End-User: Dialysis Centers, Hospital And Clinics, Research And Academic Institutes
Subsegments:
1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Sodium Bicarbonate
2) By Dialysis: Hemodialysis, Peritoneal Dialysis, Home Dialysis, Continuous Renal Replacement Therapy (CRRT)
3) By Kidney Transplantation: Living Donor Kidney Transplant, Deceased Donor Kidney Transplant, Kidney Transplant Immunosuppressive Therapy
4) By Other Treatment Types: Lifestyle And Dietary Modifications, Stem Cell Therapy, Gene Therapy
The key trends in the renal insufficiency market are:
• Medical technology advancements are driving the future of the renal insufficiency market.
• The increase in home-based treatment options is emerging as a significant trend.
• Integration of personalized medicine is becoming popular in renal insufficiency treatment.
• Advancements in dialysis technology and the development of new medications are reshaping the market.
Major players in the renal insufficiency market are:
• Kaiser Permanente
• Johnson & Johnson
• Roche Holding AG
• Sanofi S.A.
• Abbott Laboratories
• Medtronic plc
• Amgen Inc.
• Asahi Kasei Medical Co. Ltd.
• Fujifilm Holdings Corporation
• Fresenius Medical Care
• Toray Industries Inc.
• Baxter International Inc.
• Boehringer Ingelheim
• DaVita Inc.
• Eisai Co. Ltd.
• Nipro Corporation
• Biocon Limited
• HemoCue AB
• Rockwell Medical
• Mitsubishi Tanabe Pharma Corporation
• Sorin Group
North America was the largest region in the renal insufficiency market in 2024